Kiniksa Pharmaceuticals Quote - KNSA

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

18.1737

Bid

18.05

Ask

23.17

Volume

595,103

22.0201 Day's Range 22.86

16.56 52 Week Range 28.15

Market Cap

1.32B

Previous Close

22.16

Open

22.36

Last Trade

100

18.1737

(formt)

Last Trade Time

Financial Volume

US$ 13,461,704

VWAP

22.6208

Average Volume (3m)

613,226

Shares Outstanding

72,644,240

Dividend Yield

PE Ratio

-37.99

Earnings Per Share (EPS)

-0.59

Revenue

423.24M

Net Profit

-43.19M

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kiniksa.com

Headquarters

London, Gbr

Founded

Kiniksa Pharmaceuticals International PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KNSA. The last closing price for Kiniksa Pharmaceuticals was US$22.16. Over the last year, Kiniksa Pharmaceuticals shares have traded in a share price range of US$ 16.56 to US$ 28.15.

Kiniksa Pharmaceuticals currently has 72,644,240 shares outstanding. The market capitalization of Kiniksa Pharmaceuticals is US$1.61 billion. Kiniksa Pharmaceuticals has a price to earnings ratio (PE ratio) of -37.99.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-3.0063	-14.1940509915	21.18	22.94	18.1737	637748	21.67202283	CS
4	-1.7463	-8.76656626506	19.92	22.94	18.1737	699954	20.79273778	CS
12	-2.1563	-10.6064928677	20.33	22.94	17.82	613226	20.11471225	CS
26	-7.2063	-28.3936170213	25.38	28.15	17.82	468723	21.63440458	CS
52	-2.1363	-10.5184638109	20.31	28.15	16.56	432814	21.57477534	CS
156	8.5837	89.5067778936	9.59	28.15	7.36	403863	17.05470092	CS
260	0.0737	0.407182320442	18.1	33	7.36	402172	16.79459194	CS

KNSA - Frequently Asked Questions (FAQ)

What is the current Kiniksa Pharmaceuticals share price?

The current share price of Kiniksa Pharmaceuticals is US$ 18.1737

How many Kiniksa Pharmaceuticals shares are in issue?

Kiniksa Pharmaceuticals has 72,644,240 shares in issue

What is the market cap of Kiniksa Pharmaceuticals?

The market capitalisation of Kiniksa Pharmaceuticals is USD 1.61B

What is the 1 year trading range for Kiniksa Pharmaceuticals share price?

Kiniksa Pharmaceuticals has traded in the range of US$ 16.56 to US$ 28.15 during the past year

What is the PE ratio of Kiniksa Pharmaceuticals?

The price to earnings ratio of Kiniksa Pharmaceuticals is -37.99

What is the cash to sales ratio of Kiniksa Pharmaceuticals?

The cash to sales ratio of Kiniksa Pharmaceuticals is 3.88

What is the reporting currency for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Kiniksa Pharmaceuticals?

The latest annual turnover of Kiniksa Pharmaceuticals is USD 423.24M

What is the latest annual profit for Kiniksa Pharmaceuticals?

The latest annual profit of Kiniksa Pharmaceuticals is USD -43.19M

What is the registered address of Kiniksa Pharmaceuticals?

The registered address for Kiniksa Pharmaceuticals is THIRD FLOOR, 23 OLD BOND STREET, LONDON, W1S 4PZ

What is the Kiniksa Pharmaceuticals website address?

The website address for Kiniksa Pharmaceuticals is www.kiniksa.com

Which industry sector does Kiniksa Pharmaceuticals operate in?

Kiniksa Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RDUSRadius Recycling Inc	US$ 27.902 (104.26%)	8.53M
BONBon Natural Life Ltd	US$ 1.40 (90.29%)	84M
SUNESUNation Energy Inc	US$ 0.5213 (62.96%)	513.96M
WHLRLWheeler Real Estate Investment Trust Inc	US$ 255.00 (39.80%)	222
AAOIApplied Optoelectronics Inc	US$ 22.105 (39.29%)	17.01M
GLSTUGlobal Star Acquisition Inc	US$ 2.00 (-69.23%)	421
CURRCurrenc Group Inc	US$ 2.03 (-41.33%)	1.42M
ADTXAditxt Inc	US$ 0.0201 (-39.82%)	240.2M
HEPAHepion Pharmaceuticals Inc	US$ 0.0228 (-39.68%)	161.52M
WKSPWorksport Ltd	US$ 0.36205 (-35.45%)	4.96M
SUNESUNation Energy Inc	US$ 0.5213 (62.96%)	513.96M
NVDANVIDIA Corporation	US$ 121.67 (5.27%)	277.56M
ADTXAditxt Inc	US$ 0.0201 (-39.82%)	240.2M
HEPAHepion Pharmaceuticals Inc	US$ 0.0228 (-39.68%)	161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9.225 (7.64%)	160.21M